GrowBLOX Sciences Inc. (OTC:GBLX)Detailed Quote
GrowBLOX Sciences, Inc.—aka GB Sciences (OTCQB: GBLX)—merges state-of-the-art technologies in plant biology, cultivation technology and post-production processes in order to optimize our safe and consistent medicinal cannabis. The company is pioneering technology, industry-leading processes, and a big data-driven clinical research and development algorithm to bring relief to patients in communities across the country.
- Nanotechnology Research Collaboration with Universidad de Sevilla to Create Time-Released Formulation for GB Sciences’ THC-Free Chronic Pain Therapy
- Innovative Partnership Forged Between LSU AgCenter And GB Sciences To Advance The Understanding Of The Cannabis Plant
- GB Sciences Sells First Cannabis Harvest and Officially Enters Revenue Mode
- GB Sciences Wins Louisiana State University (LSU) Bid to Act as LSU Agricultural Center’s Exclusive Operator of Medical Cannabis Production Facility
- GB Sciences Builds Broad Cannabis Patent Portfolio
Around the Web
- GB Sciences Hits Milestone After Teaming With LSU Agricultural Research Center
- GB Sciences Declares A “Research Revolution” At Its “2018 Innovation In Medical Cannabis Therapies” Symposium
- GB Sciences and The Colorado Hemp Project Sell First Hemp Crop for $0.7 Million Dollars
- Dr. Andrea Small-Howard, GB Sciences’ Chief Science Officer, Introduces, “Unique Methods to Identify Strong Lead Compounds” at the International Cannabinoid Derived Pharmaceutical Summit
- GB Sciences and Louisiana State University Agricultural Center Enter a Joint Research and Development Agreement for the Production of Therapeutic Cannabis Targeting Severe Medical Conditions and Diseases
Follow Us on Social Media
Cannabis Financial Network (CannabisFN) is brought to you by TDM Financial, a financial media group and owner of SECFilings.com with over a decade of experience educating the markets, profiling public and private companies, and developing specific investor audiences. CannabisFN is the largest dedicated financial network covering the cannabis and medical marijuana (MMJ) industries and publishes industry news, thought leader and executive interviews, and stories on the fluid business and regulatory environment while serving as a leading corporate communications platform for companies operating in the industry.
Disclaimer: Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/.